Origin, fate and control of pharmaceuticals in the urban water cycle: a case study

Roberta Hofman-Caris, Thomas ter Laak, Hans Huiting, Harry Tolkamp, Ad de Man, Peter Van Diepenbeek, Johannes Hofman

Research output: Contribution to journalArticle

Abstract

Pharmaceuticals and metabolites in surface waters are of increasing concern for the aquatic environment and drinking water production. Demographic developments and climate change result in increasing environmental concentrations, deeming abatement measures necessary. Here, we report on an extensive case study around the river Meuse and its tributaries in the south of The Netherlands. For the first time, concentrations in the tributaries were measured and their apportionment to a drinking water intake downstream were calculated and measured. Large variations, depending on the river discharge were observed. At low discharge, total concentrations up to 40 µg/L were detected, with individual pharmaceuticals exceeding thresholds of toxicological concern and ecological water quality standards. Several abatement options were evaluated. Abatement at all WWTPs would result in a good chemical and ecological water quality in the rivers. Considering long implementation periods and high investment costs, we recommend prioritizing additional treatment at the WWTPs with a high contribution to the environment. If drinking water quality is at risk, temporary treatment solutions at the drinking water production can be considered. Pilot plant research proved that UV oxidation is a suitable solution for drinking and wastewater water treatment, the latter preferably in combination with effluent organic matter removal.
Original languageEnglish
Article number1034
JournalWater
DOIs
Publication statusPublished - 17 May 2019

Keywords

  • Pharmaceuticals
  • Water quality
  • Water treatment
  • Wastewater treatment
  • Abatement options

Cite this

Hofman-Caris, R., ter Laak, T., Huiting, H., Tolkamp, H., de Man, A., Van Diepenbeek, P., & Hofman, J. (2019). Origin, fate and control of pharmaceuticals in the urban water cycle: a case study. Water, [1034]. https://doi.org/10.3390/w11051034

Origin, fate and control of pharmaceuticals in the urban water cycle: a case study. / Hofman-Caris, Roberta; ter Laak, Thomas; Huiting, Hans; Tolkamp, Harry; de Man, Ad; Van Diepenbeek, Peter; Hofman, Johannes.

In: Water, 17.05.2019.

Research output: Contribution to journalArticle

Hofman-Caris, R, ter Laak, T, Huiting, H, Tolkamp, H, de Man, A, Van Diepenbeek, P & Hofman, J 2019, 'Origin, fate and control of pharmaceuticals in the urban water cycle: a case study', Water. https://doi.org/10.3390/w11051034
Hofman-Caris R, ter Laak T, Huiting H, Tolkamp H, de Man A, Van Diepenbeek P et al. Origin, fate and control of pharmaceuticals in the urban water cycle: a case study. Water. 2019 May 17. 1034. https://doi.org/10.3390/w11051034
Hofman-Caris, Roberta ; ter Laak, Thomas ; Huiting, Hans ; Tolkamp, Harry ; de Man, Ad ; Van Diepenbeek, Peter ; Hofman, Johannes. / Origin, fate and control of pharmaceuticals in the urban water cycle: a case study. In: Water. 2019.
@article{56cba160e9554b08a34bec505336f3b0,
title = "Origin, fate and control of pharmaceuticals in the urban water cycle: a case study",
abstract = "Pharmaceuticals and metabolites in surface waters are of increasing concern for the aquatic environment and drinking water production. Demographic developments and climate change result in increasing environmental concentrations, deeming abatement measures necessary. Here, we report on an extensive case study around the river Meuse and its tributaries in the south of The Netherlands. For the first time, concentrations in the tributaries were measured and their apportionment to a drinking water intake downstream were calculated and measured. Large variations, depending on the river discharge were observed. At low discharge, total concentrations up to 40 µg/L were detected, with individual pharmaceuticals exceeding thresholds of toxicological concern and ecological water quality standards. Several abatement options were evaluated. Abatement at all WWTPs would result in a good chemical and ecological water quality in the rivers. Considering long implementation periods and high investment costs, we recommend prioritizing additional treatment at the WWTPs with a high contribution to the environment. If drinking water quality is at risk, temporary treatment solutions at the drinking water production can be considered. Pilot plant research proved that UV oxidation is a suitable solution for drinking and wastewater water treatment, the latter preferably in combination with effluent organic matter removal.",
keywords = "Pharmaceuticals, Water quality, Water treatment, Wastewater treatment, Abatement options",
author = "Roberta Hofman-Caris and {ter Laak}, Thomas and Hans Huiting and Harry Tolkamp and {de Man}, Ad and {Van Diepenbeek}, Peter and Johannes Hofman",
year = "2019",
month = "5",
day = "17",
doi = "10.3390/w11051034",
language = "English",
journal = "Water",
issn = "2073-4441",
publisher = "MDPI",

}

TY - JOUR

T1 - Origin, fate and control of pharmaceuticals in the urban water cycle: a case study

AU - Hofman-Caris, Roberta

AU - ter Laak, Thomas

AU - Huiting, Hans

AU - Tolkamp, Harry

AU - de Man, Ad

AU - Van Diepenbeek, Peter

AU - Hofman, Johannes

PY - 2019/5/17

Y1 - 2019/5/17

N2 - Pharmaceuticals and metabolites in surface waters are of increasing concern for the aquatic environment and drinking water production. Demographic developments and climate change result in increasing environmental concentrations, deeming abatement measures necessary. Here, we report on an extensive case study around the river Meuse and its tributaries in the south of The Netherlands. For the first time, concentrations in the tributaries were measured and their apportionment to a drinking water intake downstream were calculated and measured. Large variations, depending on the river discharge were observed. At low discharge, total concentrations up to 40 µg/L were detected, with individual pharmaceuticals exceeding thresholds of toxicological concern and ecological water quality standards. Several abatement options were evaluated. Abatement at all WWTPs would result in a good chemical and ecological water quality in the rivers. Considering long implementation periods and high investment costs, we recommend prioritizing additional treatment at the WWTPs with a high contribution to the environment. If drinking water quality is at risk, temporary treatment solutions at the drinking water production can be considered. Pilot plant research proved that UV oxidation is a suitable solution for drinking and wastewater water treatment, the latter preferably in combination with effluent organic matter removal.

AB - Pharmaceuticals and metabolites in surface waters are of increasing concern for the aquatic environment and drinking water production. Demographic developments and climate change result in increasing environmental concentrations, deeming abatement measures necessary. Here, we report on an extensive case study around the river Meuse and its tributaries in the south of The Netherlands. For the first time, concentrations in the tributaries were measured and their apportionment to a drinking water intake downstream were calculated and measured. Large variations, depending on the river discharge were observed. At low discharge, total concentrations up to 40 µg/L were detected, with individual pharmaceuticals exceeding thresholds of toxicological concern and ecological water quality standards. Several abatement options were evaluated. Abatement at all WWTPs would result in a good chemical and ecological water quality in the rivers. Considering long implementation periods and high investment costs, we recommend prioritizing additional treatment at the WWTPs with a high contribution to the environment. If drinking water quality is at risk, temporary treatment solutions at the drinking water production can be considered. Pilot plant research proved that UV oxidation is a suitable solution for drinking and wastewater water treatment, the latter preferably in combination with effluent organic matter removal.

KW - Pharmaceuticals

KW - Water quality

KW - Water treatment

KW - Wastewater treatment

KW - Abatement options

U2 - 10.3390/w11051034

DO - 10.3390/w11051034

M3 - Article

JO - Water

JF - Water

SN - 2073-4441

M1 - 1034

ER -